218 results on '"van Diepen, M."'
Search Results
2. Development and external validation study combining existing models and recent data into an up-to-date prediction model for evaluating kidneys from older deceased donors for transplantation
- Author
-
Ramspek, Chava L., El Moumni, Mostafa, Wali, Eelaha, Heemskerk, Martin B.A., Pol, Robert A., Crop, Meindert J., Jansen, Nichon E., Hoitsma, Andries, Dekker, Friedo W., van Diepen, M., and Moers, Cyril
- Published
- 2021
- Full Text
- View/download PDF
3. Religiousness and Symptoms of Depression in Native and Immigrant Chronic Dialysis Patients in the Netherlands
- Author
-
Haverkamp, G. L. G., Braam, A. W., Loosman, W. L., van den Beukel, T. O., van Diepen, M., Dekker, F. W., Siegert, C. E. H., and Honig, A.
- Published
- 2020
- Full Text
- View/download PDF
4. A meta-review demonstrates improved reporting quality of qualitative reviews following the publication of COREQ- and ENTREQ-checklists, regardless of modest uptake
- Author
-
de Jong, Y., van der Willik, E. M., Milders, J., Voorend, C. G. N., Morton, Rachael L., Dekker, F. W., Meuleman, Y., and van Diepen, M.
- Published
- 2021
- Full Text
- View/download PDF
5. Sport-specific cardiac adaptation in 104 female elite athletes: MRI findings from the ELITE cohort
- Author
-
Van Hattum, J, primary, Van Diepen, M A, additional, Verwijs, S M, additional, Daems, J J N, additional, Boekholdt, S M, additional, Van Randen, A, additional, Planken, R N, additional, Groenink, M, additional, Nederveen, A J, additional, Moen, M H, additional, Wilde, A A M, additional, Pinto, Y M, additional, and Jorstad, H T, additional
- Published
- 2023
- Full Text
- View/download PDF
6. exercise-induced cardiac remodelling in elite athletes is characterized by a stronger ventricular mass-volume association in females as compared with males: MRI results from the ELITE cohort
- Author
-
Van Diepen, M, primary, Van Hattum, J C, additional, Daems, J J N, additional, Verwijs, S M, additional, Boekholdt, S M, additional, Van Randen, A, additional, Planken, R N, additional, Groenink, M, additional, Nederveen, A J, additional, Moen, M H, additional, Wilde, A A M, additional, Pinto, Y M, additional, and Jorstad, H T, additional
- Published
- 2023
- Full Text
- View/download PDF
7. Sex-specific differences in bi-atrial strain in elite athletes: results from the ELITE cohort
- Author
-
Daems, J J N, primary, Van Hattum, J C, additional, Verwijs, S M, additional, Van Der Hoeven, F M A, additional, Van Diepen, M A, additional, De Bruin - Bon, H A C M, additional, Vleugels, J, additional, Bombeld, D C M, additional, Bouma, B J, additional, Moen, M H, additional, Groenink, M, additional, Pinto, Y M, additional, and Jorstad, H T, additional
- Published
- 2023
- Full Text
- View/download PDF
8. Decline of kidney function during the pre-dialysis period in chronic kidney disease patients: a systematic review and meta-analysis
- Author
-
Janmaat CJ, van Diepen M, van Hagen CCE, Rotmans JI, Dekker FW, and Dekkers OM
- Subjects
meta-analysis ,systematic review ,kidney function decline ,dialysis ,chronic kidney disease ,pre-dialysis ,Infectious and parasitic diseases ,RC109-216 - Abstract
Cynthia J Janmaat,1 Merel van Diepen,1 Cheyenne CE van Hagen,1 Joris I Rotmans,2 Friedo W Dekker,1 Olaf M Dekkers1,2 1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands, 2Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands Purpose: Substantial heterogeneity exists in reported kidney function decline in pre-dialysis chronic kidney disease (CKD). By design, kidney function decline can be studied in CKD 3–5 cohorts or dialysis-based studies. In the latter, patients are selected based on the fact that they initiated dialysis, possibly leading to an overestimation of the true underlying kidney function decline in the pre-dialysis period. We performed a systematic review and meta-analysis to compare the kidney function decline during pre-dialysis in CKD stage 3–5 patients, in these two different study types. Patients and methods: We searched PubMed, EMBASE, Web of Science and Cochrane to identify eligible studies reporting an estimated glomerular filtration rate (eGFR) decline (mL/min/1.73 m2) in adult pre-dialysis CKD patients. Random-effects meta-analysis was performed to obtain weighted mean annual eGFR decline. Results: We included 60 studies (43 CKD 3–5 cohorts and 17 dialysis-based studies). The meta-analysis yielded a weighted annual mean (95% CI) eGFR decline during pre-dialysis of 2.4 (95% CI: 2.2, 2.6) mL/min/1.73 m2 in CKD 3–5 cohorts compared to 8.5 (95% CI: 6.8, 10.1) in dialysis-based studies (difference 6.0 [95% CI: 4.8, 7.2]). Conclusion: To conclude, dialysis-based studies report faster mean annual eGFR decline during pre-dialysis than CKD 3–5 cohorts. Thus, eGFR decline data from CKD 3–5 cohorts should be used to guide clinical decision making in CKD patients and for power calculations in randomized controlled trials with CKD progression during pre-dialysis as the outcome. Keywords: meta-analysis, systematic review, kidney function decline, dialysis, chronic kidney disease, pre-dialysis, CKD progression
- Published
- 2018
9. Vitamin K antagonist use and renal function in pre-dialysis patients
- Author
-
Voskamp PWM, Dekker FW, Rookmaaker MB, Verhaar MC, Bos WJW, van Diepen M, and Ocak G
- Subjects
Coumarins ,epidemiology ,chronic kidney disease ,glomerular filtration rate ,Infectious and parasitic diseases ,RC109-216 - Abstract
Pauline WM Voskamp,1 Friedo W Dekker,1 Maarten B Rookmaaker,2 Marianne C Verhaar,2 Willem Jan W Bos,3 Merel van Diepen,1 Gurbey Ocak2 1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; 2Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, the Netherlands; 3Department of Nephrology, Sint Antonius Hospital, Nieuwegein, the Netherlands Purpose: A post hoc analysis of a recent trial on direct oral anticoagulants versus vitamin K antagonists showed that amongst patients with mildly decreased kidney function, use of vitamin K antagonists was associated with a greater decline in renal function than use of direct oral anticoagulants. Whether these vitamin K antagonist effects are the same in pre-dialysis patients is unknown. Therefore, the aim of this study was to investigate the association between vitamin K antagonist use and the rate of renal function decline and time until start of dialysis in incident pre-dialysis patients.Methods: Data from 984 patients from the PREdialysis PAtient REcord study, a multicenter follow-up study of patients with chronic kidney disease who started pre-dialysis care in the Netherlands (1999–2011), were analyzed. Of these patients, 101 used a vitamin K antagonist. Linear mixed models were used to compare renal function decline between vitamin K antagonist users and non-users. Cox proportional hazards models were used to estimate the HR with 95% CI for starting dialysis.Results: Vitamin K antagonist use was associated with an extra change in renal function of –0.09 (95% CI –1.32 to 1.13) mL/min/1.73 m2 per year after adjustment for confounding. The adjusted HR for the start of dialysis was 1.20 (95% CI 0.85 to 1.69) in vitamin K antagonist users, compared to non-users. Conclusion: In incident pre-dialysis patients, the use of vitamin K antagonists was not associated with an accelerated kidney function decline or an earlier start of dialysis compared to non-use. The lack of knowledge on the indication for vitamin K antagonist use could lead to confounding by indication. Keywords: coumarins, epidemiology, chronic kidney disease, glomerular filtration rate
- Published
- 2018
10. The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease
- Author
-
Massy Z. A., Chesnaye N. C., Larabi I. A., Dekker F. W., Evans M., Caskey F. J., Torino C., Porto G., Szymczak M., Drechsler C., Wanner C., Jager K. J., Alvarez J. C., Schneider A., Torp A., Iwig B., Perras B., Marx C., Blaser C., Emde C., Krieter D., Fuchs D., Irmler E., Platen E., Schmidt-Gurtler H., Schlee H., Naujoks H., Schlee I., Casar S., Beige J., Rothele J., Mazur J., Hahn K., Blouin K., Neumeier K., Anding-Rost K., Schramm L., Hopf M., Wuttke N., Frischmuth N., Ichtiaris P., Kirste P., Schulz P., Aign S., Biribauer S., Manan S., Roser S., Heidenreich S., Palm S., Schwedler S., Delrieux S., Renker S., Schattel S., Stephan T., Schmiedeke T., Weinreich T., Leimbach T., Stovesand T., Bahner U., Seeger W., Cupisti A., Sagliocca A., Ferraro A., Mele A., Naticchia A., Cosaro A., Ranghino A., Stucchi A., Pignataro A., De Blasio A., Pani A., Tsalouichos A., Bellasi A., Raffaele Di Iorio B., Butti A., Abaterusso C., Somma C., D'Alessandro C., Zullo C., Pozzi C., Bergamo D., Ciurlino D., Motta D., Russo D., Favaro E., Vigotti F., Ansali F., Conte F., Cianciotta F., Giacchino F., Cappellaio F., Pizzarelli F., Greco G., Bigatti G., Marinangeli G., Cabiddu G., Fumagalli G., Caloro G., Piccoli G., Capasso G., Gambaro G., Tognarelli G., Bonforte G., Conte G., Toscano G., Del Rosso G., Capizzi I., Baragetti I., Oldrizzi L., Gesualdo L., Biancone L., Magnano M., Ricardi M., Di Bari M., Laudato M., Luisa Sirico M., Ferraresi M., Provenzano M., Malaguti M., Palmieri N., Murrone P., Cirillo P., Dattolo P., Acampora P., Nigro R., Boero R., Scarpioni R., Sicoli R., Malandra R., Savoldi S., Bertoli S., Borrelli S., Maxia S., Maffei S., Mangano S., Cicchetti T., Rappa T., Palazzo V., De Simone W., Schrander A., Van Dam B., Siegert C., Gaillard C., Beerenhout C., Verburgh C., Janmaat C., Hoogeveen E., Hoorn E., Boots J., Boom H., Eijgenraam J. -W., Kooman J., Rotmans J., Vogt L., Raasveld M., Vervloet M., Van Buren M., Van Diepen M., Leurs P., Voskamp P., Blankestijn P., Van Esch S., Boorsma S., Berger S., Konings C., Aydin Z., Musiala A., Szymczak A., Olczyk E., Augustyniak-Bartosik H., Miskowiec-Wisniewska I., Manitius J., Pondel J., Jedrzejak K., Nowanska K., Nowak L., Durlik M., Dorota S., Nieszporek T., Heleniak Z., Jonsson A., Blom A. -L., Rogland B., Wallquist C., Vargas D., Dimeny E., Sundelin F., Uhlin F., Welander G., Bascaran Hernandez I., Grontoft K. -C., Stendahl M., Svensson M., Heimburger O., Kashioulis P., Melander S., Almquist T., Jensen U., Woodman A., McKeever A., Ullah A., McLaren B., Harron C., Barrett C., O'Toole C., Summersgill C., Geddes C., Glowski D., McGlynn D., Sands D., Roy G., Hirst G., King H., McNally H., Masri-Senghor H., Murtagh H., Rayner H., Turner J., Wilcox J., Berdeprado J., Wong J., Banda J., Jones K., Haydock L., Wilkinson L., Carmody M., Weetman M., Joinson M., Dutton M., Matthews M., Morgan N., Bleakley N., Cockwell P., Roderick P., Mason P., Kalra P., Sajith R., Chapman S., Navjee S., Crosbie S., Brown S., Tickle S., Mathavakkannan S., Kuan Y., Massy, Z. A., Chesnaye, N. C., Larabi, I. A., Dekker, F. W., Evans, M., Caskey, F. J., Torino, C., Porto, G., Szymczak, M., Drechsler, C., Wanner, C., Jager, K. J., Alvarez, J. C., Schneider, A., Torp, A., Iwig, B., Perras, B., Marx, C., Blaser, C., Emde, C., Krieter, D., Fuchs, D., Irmler, E., Platen, E., Schmidt-Gurtler, H., Schlee, H., Naujoks, H., Schlee, I., Casar, S., Beige, J., Rothele, J., Mazur, J., Hahn, K., Blouin, K., Neumeier, K., Anding-Rost, K., Schramm, L., Hopf, M., Wuttke, N., Frischmuth, N., Ichtiaris, P., Kirste, P., Schulz, P., Aign, S., Biribauer, S., Manan, S., Roser, S., Heidenreich, S., Palm, S., Schwedler, S., Delrieux, S., Renker, S., Schattel, S., Stephan, T., Schmiedeke, T., Weinreich, T., Leimbach, T., Stovesand, T., Bahner, U., Seeger, W., Cupisti, A., Sagliocca, A., Ferraro, A., Mele, A., Naticchia, A., Cosaro, A., Ranghino, A., Stucchi, A., Pignataro, A., De Blasio, A., Pani, A., Tsalouichos, A., Bellasi, A., Raffaele Di Iorio, B., Butti, A., Abaterusso, C., Somma, C., D'Alessandro, C., Zullo, C., Pozzi, C., Bergamo, D., Ciurlino, D., Motta, D., Russo, D., Favaro, E., Vigotti, F., Ansali, F., Conte, F., Cianciotta, F., Giacchino, F., Cappellaio, F., Pizzarelli, F., Greco, G., Bigatti, G., Marinangeli, G., Cabiddu, G., Fumagalli, G., Caloro, G., Piccoli, G., Capasso, G., Gambaro, G., Tognarelli, G., Bonforte, G., Conte, G., Toscano, G., Del Rosso, G., Capizzi, I., Baragetti, I., Oldrizzi, L., Gesualdo, L., Biancone, L., Magnano, M., Ricardi, M., Di Bari, M., Laudato, M., Luisa Sirico, M., Ferraresi, M., Provenzano, M., Malaguti, M., Palmieri, N., Murrone, P., Cirillo, P., Dattolo, P., Acampora, P., Nigro, R., Boero, R., Scarpioni, R., Sicoli, R., Malandra, R., Savoldi, S., Bertoli, S., Borrelli, S., Maxia, S., Maffei, S., Mangano, S., Cicchetti, T., Rappa, T., Palazzo, V., De Simone, W., Schrander, A., Van Dam, B., Siegert, C., Gaillard, C., Beerenhout, C., Verburgh, C., Janmaat, C., Hoogeveen, E., Hoorn, E., Boots, J., Boom, H., Eijgenraam, J. -W., Kooman, J., Rotmans, J., Vogt, L., Raasveld, M., Vervloet, M., Van Buren, M., Van Diepen, M., Leurs, P., Voskamp, P., Blankestijn, P., Van Esch, S., Boorsma, S., Berger, S., Konings, C., Aydin, Z., Musiala, A., Szymczak, A., Olczyk, E., Augustyniak-Bartosik, H., Miskowiec-Wisniewska, I., Manitius, J., Pondel, J., Jedrzejak, K., Nowanska, K., Nowak, L., Durlik, M., Dorota, S., Nieszporek, T., Heleniak, Z., Jonsson, A., Blom, A. -L., Rogland, B., Wallquist, C., Vargas, D., Dimeny, E., Sundelin, F., Uhlin, F., Welander, G., Bascaran Hernandez, I., Grontoft, K. -C., Stendahl, M., Svensson, M., Heimburger, O., Kashioulis, P., Melander, S., Almquist, T., Jensen, U., Woodman, A., Mckeever, A., Ullah, A., Mclaren, B., Harron, C., Barrett, C., O'Toole, C., Summersgill, C., Geddes, C., Glowski, D., Mcglynn, D., Sands, D., Roy, G., Hirst, G., King, H., Mcnally, H., Masri-Senghor, H., Murtagh, H., Rayner, H., Turner, J., Wilcox, J., Berdeprado, J., Wong, J., Banda, J., Jones, K., Haydock, L., Wilkinson, L., Carmody, M., Weetman, M., Joinson, M., Dutton, M., Matthews, M., Morgan, N., Bleakley, N., Cockwell, P., Roderick, P., Mason, P., Kalra, P., Sajith, R., Chapman, S., Navjee, S., Crosbie, S., Brown, S., Tickle, S., Mathavakkannan, S., Kuan, Y., Nephrology, ACS - Diabetes & metabolism, Medical Informatics, APH - Methodology, APH - Aging & Later Life, APH - Quality of Care, APH - Global Health, APH - Health Behaviors & Chronic Diseases, and ACS - Pulmonary hypertension & thrombosis
- Subjects
Transplantation ,Nephrology ,uremic toxins ,CKD ,symptoms ,symptom ,elderly - Abstract
Background Patients with stage 4/5 chronic kidney disease (CKD) suffer from various symptoms. The retention of uremic solutes is thought to be associated with those symptoms. However, there are relatively few rigorous studies on the potential links between uremic toxins and symptoms in patients with CKD. Methods The EQUAL study is an ongoing observational cohort study of non-dialyzed patients with stage 4/5 CKD. EQUAL patients from Germany, Poland, Sweden and the UK were included in the present study (n = 795). Data and symptom self-report questionnaires were collected between April 2012 and September 2020. Baseline uric acid and parathyroid hormone and 10 uremic toxins were quantified. We tested the association between uremic toxins and symptoms and adjusted P-values for multiple testing. Results Symptoms were more frequent in women than in men with stage 4/5 CKD, while levels of various uremic toxins were higher in men. Only trimethylamine N-oxide (TMAO; positive association with fatigue), p-cresyl sulfate (PCS) with constipation and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (negative association with shortness of breath) demonstrated moderately strong associations with symptoms in adjusted analyses. The association of phenylacetylglutamine with shortness of breath was consistent in both sexes, although it only reached statistical significance in the full population. In contrast, TMAO (fatigue) and PCS and phenylacetylglutamine (constipation) were only associated with symptoms in men, who presented higher serum levels than women. Conclusion Only a limited number of toxins were associated with symptoms in persons with stage 4/5 CKD. Other uremic toxins, uremia-related factors or psychosocial factors not yet explored might contribute to symptom burden.
- Published
- 2022
- Full Text
- View/download PDF
11. Prediction models for the mortality risk in chronic dialysis patients: a systematic review and independent external validation study
- Author
-
Ramspek CL, Voskamp PWM, van Ittersum FJ, Krediet RT, Dekker FW, and van Diepen M
- Subjects
External validation ,prediction ,nephrology ,dialysis ,mortality. ,Infectious and parasitic diseases ,RC109-216 - Abstract
Chava L Ramspek,1 Pauline WM Voskamp,1 Frans J van Ittersum,2 Raymond T Krediet,3 Friedo W Dekker,1 Merel van Diepen1 On behalf of the NECOSAD study group 1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, 2Department of Nephrology, VU University Medical Center, 3Department of Nephrology, Academic Medical Center, Amsterdam, The Netherlands Objective: In medicine, many more prediction models have been developed than are implemented or used in clinical practice. These models cannot be recommended for clinical use before external validity is established. Though various models to predict mortality in dialysis patients have been published, very few have been validated and none are used in routine clinical practice. The aim of the current study was to identify existing models for predicting mortality in dialysis patients through a review and subsequently to externally validate these models in the same large independent patient cohort, in order to assess and compare their predictive capacities.Methods: A systematic review was performed following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. To account for missing data, multiple imputation was performed. The original prediction formulae were extracted from selected studies. The probability of death per model was calculated for each individual within the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD). The predictive performance of the models was assessed based on their discrimination and calibration.Results: In total, 16 articles were included in the systematic review. External validation was performed in 1,943 dialysis patients from NECOSAD for a total of seven models. The models performed moderately to well in terms of discrimination, with C-statistics ranging from 0.710 (interquartile range 0.708–0.711) to 0.752 (interquartile range 0.750–0.753) for a time frame of 1 year. According to the calibration, most models overestimated the probability of death.Conclusion: Overall, the performance of the models was poorer in the external validation than in the original population, affirming the importance of external validation. Floege et al’s models showed the highest predictive performance. The present study is a step forward in the use of a prediction model as a useful tool for nephrologists, using evidence-based medicine that combines individual clinical expertise, patients’ choices, and the best available external evidence. Keywords: external validation, prediction, nephrology, dialysis, mortality
- Published
- 2017
12. Effect of glomerular filtration rate at dialysis initiation on survival in patients with advanced chronic kidney disease: what is the effect of lead-time bias?
- Author
-
Janmaat CJ, van Diepen M, Krediet RT, Hemmelder MH, and Dekker FW
- Subjects
end stage renal disease ,epidemiology ,hazard model ,kidney function ,lead-time ,linear interpolation model ,Infectious and parasitic diseases ,RC109-216 - Abstract
Cynthia J Janmaat,1 Merel van Diepen,1 Raymond T Krediet,2 Marc H Hemmelder,3 Friedo W Dekker1 On behalf of the NECOSAD study group 1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, 2Department of Nephrology, Academic Medical Center, Amsterdam, 3Department of Internal Medicine, Nefrovisie Foundation, Utrecht, Netherlands Purpose: Current clinical guidelines recommend to initiate dialysis in the presence of symptoms or signs attributable to kidney failure, often with a glomerular filtration rate (GFR) of 5–10 mL/min/1.73 m2. Little evidence exists about the optimal kidney function to start dialysis. Thus far, most observational studies have been limited by lead-time bias. Only a few studies have accounted for lead-time bias, and showed contradictory results. We examined the effect of GFR at dialysis initiation on survival in chronic kidney disease patients, and the role of lead-time bias therein. We used both kidney function based on 24-hour urine collection (measured GFR [mGFR]) and estimated GFR (eGFR). Materials and methods: A total of 1,143 patients with eGFR data at dialysis initiation and 852 patients with mGFR data were included from the NECOSAD cohort. Cox regression was used to adjust for potential confounders. To examine the effect of lead-time bias, survival was counted from the time of dialysis initiation or from a common starting point (GFR 20 mL/min/1.73 m2), using linear interpolation models. Results: Without lead-time correction, no difference between early and late starters was present based on eGFR (hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.81–1.3). However, after lead-time correction, early initiation showed a survival disadvantage (HR between 1.1 [95% CI 0.82–1.48] and 1.33 [95% CI 1.05–1.68]). Based on mGFR, the potential survival benefit for early starters without lead-time correction (HR 0.8, 95% CI 0.62–1.03) completely disappeared after lead-time correction (HR between 0.94 [95% CI 0.65–1.34] and 1.21 [95% CI 0.95–1.56]). Dialysis start time differed about a year between early and late initiation. Conclusion: Lead-time bias is not only a methodological problem but also has clinical impact when assessing the optimal kidney function to start dialysis. Therefore, lead-time bias is extremely important to correct for. Taking account of lead-time bias, this controlled study showed that early dialysis initiation (eGFR >7.9, mGFR >6.6 mL/min/1.73 m2) was not associated with an improvement in survival. Based on kidney function, this study suggests that in some patients, dialysis could be started even later than an eGFR
- Published
- 2017
13. Exercise-induced cardiovascular remodelling in a large cohort of female, elite athletes: towards sex-specific CMR reference ranges
- Author
-
Van Hattum, J, primary, Van Diepen, M A, additional, Verwijs, S M, additional, Daems, J J N, additional, Boekholdt, S M, additional, Van Randen, A, additional, Planken, R N, additional, Groenink, M, additional, Nederveen, A J, additional, Moen, M H, additional, Wilde, A A M, additional, Pinto, Y M, additional, and Jorstad, H T, additional
- Published
- 2023
- Full Text
- View/download PDF
14. External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019
- Author
-
Hassan, S, Ramspek, C, Ferrari, B, van Diepen, M, Rossio, R, Knevel, R, la Mura, V, Artoni, A, Martinelli, I, Bandera, A, Nobili, A, Gori, A, Blasi, F, Canetta, C, Montano, N, Rosendaal, F, Peyvandi, F, Bosari, S, Scudeller, L, Fusetti, G, Rusconi, L, Dell'Orto, S, Prati, D, Valenti, L, Giovannelli, S, Manunta, M, Lamorte, G, Ferarri, F, Muscatello, A, Mangioni, D, Alagna, L, Bozzi, G, Lombardi, A, Ungaro, R, Ancona, G, Zuglian, G, Bolis, M, Iannotti, N, Ludovisi, S, Comelli, A, Renisi, G, Biscarini, S, Castelli, V, Palomba, E, Fava, M, Fortina, V, Peri, C, Saltini, P, Viero, G, Itri, T, Ferroni, V, Pastore, V, Massafra, R, Liparoti, A, Muheberimana, T, Giommi, A, Bianco, R, De Azevedo, R, Chitani, G, Gualtierotti, R, Boasi, N, Pagliaro, E, Massimo, C, De Caro, M, Giachi, A, Vigone, B, Bellocchi, C, Carandina, A, Fiorelli, E, Melli, V, Tobaldini, E, Aliberti, S, Spotti, M, Terranova, L, Misuraca, S, D'Adda, A, Fiore, S, Di Pasquale, M, Mantero, M, Contarini, M, Ori, M, Morlacchi, L, Rossetti, V, Gramegna, A, Pappalettera, M, Cavallini, M, Buscemi, A, Vicenzi, M, Rota, I, Costantino, G, Solbiati, M, Furlan, L, Mancarella, M, Colombo, G, Fanin, A, Passarella, M, Monzani, V, Rovellini, A, Barbetta, L, Billi, F, Folli, C, Accordino, S, Maira, D, Hu, C, Motta, I, Scar-Amellini, N, Fracanzani, A, Lombardi, R, Cespiati, A, Cesari, M, Lucchi, T, Proietti, M, Calcaterra, L, Mandelli, C, Coppola, C, Cerizza, A, Maria Pesenti, A, Grasselli, G, Galazzi, A, Tet-Tamanti, M, Monti, I, Galbussera, A, Crisafulli, E, Girelli, D, Maroccia, A, Gabbiani, D, Busti, F, Vianello, A, Biondan, M, Sartori, F, Faverio, P, Pesci, A, Zucchetti, S, Bonfanti, P, Rossi, M, Beretta, I, Spolti, A, Harari, S, Elia, D, Cassandro, R, Caminati, A, Cipollone, F, Guagnano, M, D'Ardes, D, Rossi, I, Vezzani, F, Spanevello, A, Cherubino, F, Visca, D, Contoli, M, Papi, A, Morandi, L, Battistini, N, Luigi Moreo, G, Iannuzzi, P, Fumagalli, D, Leone, S, Oud, J, Baysan, M, Wigb, J, van Heurn, L, ter Haar, S, Toppenberg, A, Heerdink, L, van IJlzinga Veenstra, A, Eikenboom, A, Wubbolts, J, Uzorka, J, Lijferink, W, Meier, R, de Jonge, I, Arbous, S, de Boer, M, van der Bom, J, Dekkers, O, Hassan S., Ramspek C. L., Ferrari B., van Diepen M., Rossio R., Knevel R., la Mura V., Artoni A., Martinelli I., Bandera A., Nobili A., Gori A., Blasi F., Canetta C., Montano N., Rosendaal F. R., Peyvandi F., Bosari S., Scudeller L., Fusetti G., Rusconi L., Dell'Orto S., Prati D., Valenti L., Giovannelli S., Manunta M., Lamorte G., Ferarri F., Muscatello A., Mangioni D., Alagna L., Bozzi G., Lombardi A., Ungaro R., Ancona G., Zuglian G., Bolis M., Iannotti N., Ludovisi S., Comelli A., Renisi G., Biscarini S., Castelli V., Palomba E., Fava M., Fortina V., Peri C. A., Saltini P., Viero G., Itri T., Ferroni V., Pastore V., Massafra R., Liparoti A., Muheberimana T., Giommi A., Bianco R., De Azevedo R. M., Chitani G. E., Gualtierotti R., Boasi N., Pagliaro E., Massimo C., De Caro M., Giachi A., Vigone B., Bellocchi C., Carandina A., Fiorelli E., Melli V., Tobaldini E., Aliberti S., Spotti M., Terranova L., Misuraca S., D'Adda A., Fiore S. D., Di Pasquale M., Mantero M., Contarini M., Ori M., Morlacchi L., Rossetti V., Gramegna A., Pappalettera M., Cavallini M., Buscemi A., Vicenzi M., Rota I., Costantino G., Solbiati M., Furlan L., Mancarella M., Colombo G., Fanin A., Passarella M., Monzani V., Rovellini A., Barbetta L., Billi F., Folli C., Accordino S., Maira D., Hu C. M., Motta I., Scar-Amellini N., Fracanzani A. L., Lombardi R., Cespiati A., Cesari M., Lucchi T., Proietti M., Calcaterra L., Mandelli C., Coppola C., Cerizza A., Maria Pesenti A., Grasselli G., Galazzi A., Tet-Tamanti M., Monti I., Galbussera A. A., Crisafulli E., Girelli D., Maroccia A., Gabbiani D., Busti F., Vianello A., Biondan M., Sartori F., Faverio P., Pesci A., Zucchetti S., Bonfanti P., Rossi M., Beretta I., Spolti A., Harari S., Elia D., Cassandro R., Caminati A., Cipollone F., Guagnano M. T., D'Ardes D., Rossi I., Vezzani F., Spanevello A., Cherubino F., Visca D., Contoli M., Papi A., Morandi L., Battistini N., Luigi Moreo G., Iannuzzi P., Fumagalli D., Leone S., Oud J. A., Baysan M., Wigb J., van Heurn L. J., ter Haar S. B., Toppenberg A. G. L., Heerdink L., van IJlzinga Veenstra A. A., Eikenboom A. M., Wubbolts J., Uzorka J., Lijferink W., Meier R., de Jonge I. -B., Arbous S. M., de Boer M. G. J., van der Bom J. G., Dekkers O. M., Hassan, S, Ramspek, C, Ferrari, B, van Diepen, M, Rossio, R, Knevel, R, la Mura, V, Artoni, A, Martinelli, I, Bandera, A, Nobili, A, Gori, A, Blasi, F, Canetta, C, Montano, N, Rosendaal, F, Peyvandi, F, Bosari, S, Scudeller, L, Fusetti, G, Rusconi, L, Dell'Orto, S, Prati, D, Valenti, L, Giovannelli, S, Manunta, M, Lamorte, G, Ferarri, F, Muscatello, A, Mangioni, D, Alagna, L, Bozzi, G, Lombardi, A, Ungaro, R, Ancona, G, Zuglian, G, Bolis, M, Iannotti, N, Ludovisi, S, Comelli, A, Renisi, G, Biscarini, S, Castelli, V, Palomba, E, Fava, M, Fortina, V, Peri, C, Saltini, P, Viero, G, Itri, T, Ferroni, V, Pastore, V, Massafra, R, Liparoti, A, Muheberimana, T, Giommi, A, Bianco, R, De Azevedo, R, Chitani, G, Gualtierotti, R, Boasi, N, Pagliaro, E, Massimo, C, De Caro, M, Giachi, A, Vigone, B, Bellocchi, C, Carandina, A, Fiorelli, E, Melli, V, Tobaldini, E, Aliberti, S, Spotti, M, Terranova, L, Misuraca, S, D'Adda, A, Fiore, S, Di Pasquale, M, Mantero, M, Contarini, M, Ori, M, Morlacchi, L, Rossetti, V, Gramegna, A, Pappalettera, M, Cavallini, M, Buscemi, A, Vicenzi, M, Rota, I, Costantino, G, Solbiati, M, Furlan, L, Mancarella, M, Colombo, G, Fanin, A, Passarella, M, Monzani, V, Rovellini, A, Barbetta, L, Billi, F, Folli, C, Accordino, S, Maira, D, Hu, C, Motta, I, Scar-Amellini, N, Fracanzani, A, Lombardi, R, Cespiati, A, Cesari, M, Lucchi, T, Proietti, M, Calcaterra, L, Mandelli, C, Coppola, C, Cerizza, A, Maria Pesenti, A, Grasselli, G, Galazzi, A, Tet-Tamanti, M, Monti, I, Galbussera, A, Crisafulli, E, Girelli, D, Maroccia, A, Gabbiani, D, Busti, F, Vianello, A, Biondan, M, Sartori, F, Faverio, P, Pesci, A, Zucchetti, S, Bonfanti, P, Rossi, M, Beretta, I, Spolti, A, Harari, S, Elia, D, Cassandro, R, Caminati, A, Cipollone, F, Guagnano, M, D'Ardes, D, Rossi, I, Vezzani, F, Spanevello, A, Cherubino, F, Visca, D, Contoli, M, Papi, A, Morandi, L, Battistini, N, Luigi Moreo, G, Iannuzzi, P, Fumagalli, D, Leone, S, Oud, J, Baysan, M, Wigb, J, van Heurn, L, ter Haar, S, Toppenberg, A, Heerdink, L, van IJlzinga Veenstra, A, Eikenboom, A, Wubbolts, J, Uzorka, J, Lijferink, W, Meier, R, de Jonge, I, Arbous, S, de Boer, M, van der Bom, J, Dekkers, O, Hassan S., Ramspek C. L., Ferrari B., van Diepen M., Rossio R., Knevel R., la Mura V., Artoni A., Martinelli I., Bandera A., Nobili A., Gori A., Blasi F., Canetta C., Montano N., Rosendaal F. R., Peyvandi F., Bosari S., Scudeller L., Fusetti G., Rusconi L., Dell'Orto S., Prati D., Valenti L., Giovannelli S., Manunta M., Lamorte G., Ferarri F., Muscatello A., Mangioni D., Alagna L., Bozzi G., Lombardi A., Ungaro R., Ancona G., Zuglian G., Bolis M., Iannotti N., Ludovisi S., Comelli A., Renisi G., Biscarini S., Castelli V., Palomba E., Fava M., Fortina V., Peri C. A., Saltini P., Viero G., Itri T., Ferroni V., Pastore V., Massafra R., Liparoti A., Muheberimana T., Giommi A., Bianco R., De Azevedo R. M., Chitani G. E., Gualtierotti R., Boasi N., Pagliaro E., Massimo C., De Caro M., Giachi A., Vigone B., Bellocchi C., Carandina A., Fiorelli E., Melli V., Tobaldini E., Aliberti S., Spotti M., Terranova L., Misuraca S., D'Adda A., Fiore S. D., Di Pasquale M., Mantero M., Contarini M., Ori M., Morlacchi L., Rossetti V., Gramegna A., Pappalettera M., Cavallini M., Buscemi A., Vicenzi M., Rota I., Costantino G., Solbiati M., Furlan L., Mancarella M., Colombo G., Fanin A., Passarella M., Monzani V., Rovellini A., Barbetta L., Billi F., Folli C., Accordino S., Maira D., Hu C. M., Motta I., Scar-Amellini N., Fracanzani A. L., Lombardi R., Cespiati A., Cesari M., Lucchi T., Proietti M., Calcaterra L., Mandelli C., Coppola C., Cerizza A., Maria Pesenti A., Grasselli G., Galazzi A., Tet-Tamanti M., Monti I., Galbussera A. A., Crisafulli E., Girelli D., Maroccia A., Gabbiani D., Busti F., Vianello A., Biondan M., Sartori F., Faverio P., Pesci A., Zucchetti S., Bonfanti P., Rossi M., Beretta I., Spolti A., Harari S., Elia D., Cassandro R., Caminati A., Cipollone F., Guagnano M. T., D'Ardes D., Rossi I., Vezzani F., Spanevello A., Cherubino F., Visca D., Contoli M., Papi A., Morandi L., Battistini N., Luigi Moreo G., Iannuzzi P., Fumagalli D., Leone S., Oud J. A., Baysan M., Wigb J., van Heurn L. J., ter Haar S. B., Toppenberg A. G. L., Heerdink L., van IJlzinga Veenstra A. A., Eikenboom A. M., Wubbolts J., Uzorka J., Lijferink W., Meier R., de Jonge I. -B., Arbous S. M., de Boer M. G. J., van der Bom J. G., and Dekkers O. M.
- Abstract
Background: The coronavirus disease 2019 (COVID-19) presents an urgent threat to global health. Prediction models that accurately estimate mortality risk in hospitalized patients could assist medical staff in treatment and allocating limited resources. Aims: To externally validate two promising previously published risk scores that predict in-hospital mortality among hospitalized COVID-19 patients. Methods: Two prospective cohorts were available; a cohort of 1028 patients admitted to one of nine hospitals in Lombardy, Italy (the Lombardy cohort) and a cohort of 432 patients admitted to a hospital in Leiden, the Netherlands (the Leiden cohort). The endpoint was in-hospital mortality. All patients were adult and tested COVID-19 PCR-positive. Model discrimination and calibration were assessed. Results: The C-statistic of the 4C mortality score was good in the Lombardy cohort (0.85, 95CI: 0.82−0.89) and in the Leiden cohort (0.87, 95CI: 0.80−0.94). Model calibration was acceptable in the Lombardy cohort but poor in the Leiden cohort due to the model systematically overpredicting the mortality risk for all patients. The C-statistic of the CURB-65 score was good in the Lombardy cohort (0.80, 95CI: 0.75−0.85) and in the Leiden cohort (0.82, 95CI: 0.76−0.88). The mortality rate in the CURB-65 development cohort was much lower than the mortality rate in the Lombardy cohort. A similar but less pronounced trend was found for patients in the Leiden cohort. Conclusion: Although performances did not differ greatly, the 4C mortality score showed the best performance. However, because of quickly changing circumstances, model recalibration may be necessary before using the 4C mortality score.
- Published
- 2022
15. A formal semantics for Z and the link between Z and the relational algebra
- Author
-
van Diepen, M. J., van Hee, K. M., Goos, G., editor, Hartmanis, J., editor, Barstow, D., editor, Brauer, W., editor, Brinch Hansen, P., editor, Gries, D., editor, Luckham, D., editor, Moler, C., editor, Pnueli, A., editor, Seegmüller, G., editor, Stoer, J., editor, Wirth, N., editor, Bjørner, D., editor, Hoare, C. A. R., editor, and Langmaack, H., editor
- Published
- 1990
- Full Text
- View/download PDF
16. Additional file 1 of A meta-review demonstrates improved reporting quality of qualitative reviews following the publication of COREQ- and ENTREQ-checklists, regardless of modest uptake
- Author
-
de Jong, Y., van der Willik, E. M., Milders, J., Voorend, C. G. N., Morton, Rachael L., Dekker, F. W., Meuleman, Y., and van Diepen, M.
- Subjects
Data_FILES - Abstract
Additional file 1.
- Published
- 2021
- Full Text
- View/download PDF
17. Heterologous prime boost immunisations with improved DNA, MVA and protein HIV-1 subtype C vaccines elicit Tier 2 neutralising antibodies in a Chinese rhesus monkey model
- Author
-
Chapman, R., Adams, C., Keyser, A., Van Diepen, M., Douglass, N., Morris, L., Moore, P., Williamson, A.-L., and Chege, G.
- Subjects
Viral antibodies -- Physiological aspects -- Health aspects ,Antibodies -- Physiological aspects -- Health aspects ,AIDS vaccines -- Testing -- Physiological aspects ,HIV infection -- Models -- Prevention ,Health - Abstract
Background: We previously reported establishment of a simian-human immunodeficiency virus (SHIV) challenge model using Chinese-origin rhesus macaques (ChRM) for testing the efficacy of HIV vaccines in South Africa. In the current study, we sought to establish proof of concept using a vaccine regimen that had elicited autologous Tier 2 neutralising antibodies (NAbs) in rabbits. Methods: The Env glycoprotein consensus sequence of the ChRM-adapted SHIV was determined and utilised in the vaccines designed in this study. DNA and MVA vaccines expressing SIV Gag and HIV Env antigens were constructed and in vitro expression confirmed. A soluble gp140 protein was expressed from a stable HEK293 cell line and purified using lectin affinity chromatography and gel filtration. Six ChRM were inoculated with two DNA, followed by two MVA and finally two protein vaccinations on weeks 0, 4, 8, 12, 20 and 28. Vaccine-induced T cell immunity was measured by IFN-[gamma] ELISPOT using peptide pools derived from SIV Gag and subtype C consensus Env while the NAbs were evaluated against Tier 1A (MW965.26), Tier 1B (6644.v2.c33) and Tier 2 (ZM109.B4) pseudovirions. The macaques were then challenged weekly from week 32 until they became infected. An unvaccinated control group was also challenged weekly until they became infected. Results: The expression and secretion of HIV-1 Env and SIV Gag by all three vaccine vectors was verified in vitro. Following vaccination, all the animals developed IFN-[gamma] ELISPOT responses after the DNA vaccinations (median: 255 sfu/million) which were boosted by the MVA inoculations (median: 1031 sfu/million). After protein boost, all animals had NAbs to MW965.26 (median titre: 426.5) and ZM109.B4 (median titre: 29.5) pseudovirions and 3 of 6 to 6644.v2.c33 pseudovirions. The animals in the vaccine group became infected following challenge at a similar rate to the controls, however, median peak viraemia in the vaccine group (1.8x[10.sup.3] copies/ml) was lower than the controls (1.6x[10.sup.3]/ml). Viral replication kinetics were similar in all animals with rapid decline to undetectable levels by 12 weeks post infection. Conclusions: These data provide proof of concept regarding the utility of our ChRM virus challenge model and support further testing of our novel vaccines using this model., OA18.04 R. Chapman (1); C. Adams (1); A. Keyser (1); M. van Diepen (1); N. Douglass (1); L. Morris (2); P. Moore (2); A.-L. Williamson (1) and G. Chege (3) [...]
- Published
- 2021
- Full Text
- View/download PDF
18. Pitfalls of linear regression for estimating slopes over time and how to avoid them by using linear mixed-effects models
- Author
-
Kitty J Jager, van Diepen, M., Tsonaka R, Carmine Zoccali, Cynthia J. Janmaat, Friedo W. Dekker, Nephrology, Medical Informatics, ACS - Pulmonary hypertension & thrombosis, APH - Aging & Later Life, APH - Quality of Care, and APH - Global Health
- Subjects
Nephrology ,medicine.medical_specialty ,Time Factors ,030232 urology & nephrology ,Renal function ,kidney function trajectory ,linear mixed-effects model ,030204 cardiovascular system & hematology ,dropout ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Linear regression ,medicine ,Econometrics ,Humans ,Renal Insufficiency, Chronic ,Dropout (neural networks) ,Transplantation ,Models, Statistical ,business.industry ,Linear model ,Repeated measures design ,Regression analysis ,medicine.disease ,GFR trajectory ,Linear Models ,linear regression ,Regression Analysis ,business ,Glomerular Filtration Rate ,Kidney disease - Abstract
Clinical epidemiological studies often focus on investigating the underlying causes of disease. For instance, a nephrologist may be interested in the association between blood pressure and the development of chronic kidney disease (CKD). However, instead of focusing on the mere occurrence of CKD, the decline of kidney function over time might be the outcome of interest. For examining this kidney function trajectory, patients are typically followed over time with their kidney function estimated at several time points. During follow-up, some patients may drop out earlier than others and for different reasons. Furthermore, some patients may have greater kidney function at study entry or faster kidney function decline than others. Also, a substantial heterogeneity may exist in the number of kidney function estimates available for each patient. This heterogeneity with respect to kidney function, dropout and number of kidney function estimates is important to take into account when estimating kidney function trajectories. In general, two methods are used in the literature to estimate kidney function trajectories over time: linear regression to estimate individual slopes and the linear mixed-effects model (LMM), i.e. repeated measures analysis. Importantly, the linear regression method does not properly take into account the above-mentioned heterogeneity, whereas the LMM is able to retain all information and variability in the data. However, the underlying concepts, use and interpretation of LMMs are not always straightforward. Therefore we illustrate this using a clinical example and offer a framework of how to model and interpret the LMM.
- Published
- 2019
- Full Text
- View/download PDF
19. Prediction meets causal inference: the role of treatment in clinical prediction models
- Author
-
van Geloven, N, Swanson, Sonja, Ramspek, CL, Luijken, K, van Diepen, M, Morris, TP, Groenwold, RHH, van Houwelingen, HC, Putter, H, le Cessie, S, van Geloven, N, Swanson, Sonja, Ramspek, CL, Luijken, K, van Diepen, M, Morris, TP, Groenwold, RHH, van Houwelingen, HC, Putter, H, and le Cessie, S
- Published
- 2020
20. The molluscan RING-finger protein L-TRIM is essential for neuronal outgrowth
- Author
-
van Diepen, M. T., Spencer, G. E., van Minnen, J., Gouwenberg, Y., Bouwman, J., Smit, A. B., and van Kesteren, R. E.
- Published
- 2005
- Full Text
- View/download PDF
21. Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines
- Author
-
Maas, R.A., Komen, M., van Diepen, M., Oei, H.L., and Claassen, I.J.T.M.
- Published
- 2003
- Full Text
- View/download PDF
22. HIVR4P 2018: From Research to Impact Conference Summary and Highlights
- Author
-
Shacklett, BL, Blanco, J, Hightow-Weidman, L, Mgodi, N, Alcami, J, Buchbinder, S, Chirenje, M, Dabee, S, Diallo, M, Dumchev, K, Herrera, C, Levy, ME, Gayo, EM, Makoah, NA, Mitchell, KM, Mugwanya, K, Reddy, K, Rodriguez, ML, Rodriguez-Garcia, M, Shover, CL, Shrivastava, T, Tomaras, G, Van Diepen, M, Walia, M, Warren, M, Manrique, A, Thyagarajan, B, and Torri, T
- Subjects
immunogens ,Env ,HIVR4P ,clinical trial ,bNAbs ,TasP - Abstract
The HIV Research for Prevention (HIVR4P) conference is dedicated to advancing HIV prevention research, responding to a growing consensus that effective and durable prevention will require a combination of approaches as well as unprecedented collaboration among scientists, practitioners, and community workers from different fields and geographic areas. The conference theme in 2018, "From Research to Impact," acknowledged an increasing focus on translation of promising research findings into practical, accessible, and affordable HIV prevention options for those who need them worldwide. HIVR4P 2018 was held in Madrid, Spain, on 21-25 October, with >1,400 participants from 52 countries around the globe, representing all aspects of HIV prevention research and implementation. The program included 137 oral and 610 poster presentations. This article presents a brief summary of highlights from the conference. More detailed information, complete abstracts as well as webcasts and daily Rapporteur summaries may be found on the conference website.
- Published
- 2019
23. Religiousness and Symptoms of Depression in Native and Immigrant Chronic Dialysis Patients in the Netherlands
- Author
-
Haverkamp, G. L. G., primary, Braam, A. W., additional, Loosman, W. L., additional, van den Beukel, T. O., additional, van Diepen, M., additional, Dekker, F. W., additional, Siegert, C. E. H., additional, and Honig, A., additional
- Published
- 2019
- Full Text
- View/download PDF
24. 'We staan aan de wieg van iets moois': eerste ervaringen en opbrengsten van het Keuzedeel Voorbereiding hbo
- Author
-
Vervoort, M., van Diepen, M., Elffers, L., Lectoraat Kansrijke Schoolloopbanen in een Diverse Stad, Kenniscentrum Onderwijs en Opvoeding, and Educational Sciences (RICDE, FMG)
- Abstract
Om mbo-studenten die willen doorstromen naar het hbo beter voor te bereiden op het hbo, bieden veel roc’s in samenwerking met hogescholen het Keuzedeel Voorbereiding hbo aan. In dit onderzoek zijn de eerste ervaringen en opbrengsten van het Keuzedeel onderzocht. Hiervoor zijn betrokken ontwikkelaars en uitvoerders geïnterviewd en zijn de ervaringen en leerontwikkeling van deelnemers gemeten aan de hand van een survey. Het onderzoek is tot stand gekomen in samenwerking met de onderwijsinstellingen die zijn vertegenwoordigd in het Regionaal Netwerk mbo-hbo Noord-Holland – Flevoland.
- Published
- 2018
25. Digitized validation of ECG criteria for left ventricular hypertrophy: an elite athlete CMR study
- Author
-
Van Diepen, M A, Daems, J J N, Van Hattum, J C, Verwijs, S M, Boekholdt, S M, Planken, R N, Van Randen, A, Boonstra, M J, Van Der Zwaard, S, Moen, M H, Kors, J A, Postema, P G, Bijsterveld, N R, Asselbergs, F W, and Jorstad, H T
- Published
- 2024
- Full Text
- View/download PDF
26. Sex- and cardiac magnetic resonance imaging septal thickness demonstrate the strongest associations with maximal oxygen uptake and oxygen pulse in elite athletes: findings from the ELITE cohort
- Author
-
Van Steijn, N, Beerman, F, Van Hattum, J C, Daems, J J N, Van Diepen, M A, Planken, R N, Boekholdt, S M, Moen, M, Van Randen, A, Snaterse, M, and Jorstad, H T
- Published
- 2024
- Full Text
- View/download PDF
27. Cardiac magnetic resonance imaging aids in differentiating dilated cardiomyopathy from the athlete's heart
- Author
-
Daems, J J N, Adema, B J, Kramarenko, D, Van Diepen, M A, Verwijs, S M, Van Hattum, J C, Poel, E, Moen, M H, Nelissen, J L, Van Den Boogaard, M, Van Der Crabben, S N, Amin, A S, Wilde, A A M, Asselbergs, F W, and Jorstad, H T
- Published
- 2024
- Full Text
- View/download PDF
28. Health Valuation of Dialysis with the EQ-5D: Determinants of Discrepancy Between Patients and Society
- Author
-
Beby, AT, primary, Voskamp, PW, additional, Zamanipoor Najafabadi, AH, additional, van Diepen, M, additional, and Dekker, FW, additional
- Published
- 2017
- Full Text
- View/download PDF
29. Differences in the association of inflammation and tryptophan with depression between white and non-white chronic dialysis patients
- Author
-
Haverkamp, G., primary, Loosman, W., additional, Schouten, R., additional, Franssen, C., additional, Kema, I., additional, Van Diepen, M., additional, Dekker, F., additional, Siegert, C., additional, and Honig, A., additional
- Published
- 2017
- Full Text
- View/download PDF
30. Long-term associations between inflammation and depressive symptoms in chronic dialysis patients
- Author
-
Haverkamp, G., primary, Loosman, W., additional, Schouten, R., additional, Franssen, C., additional, Kema, I., additional, Van Diepen, M., additional, Dekker, F., additional, Chandie Shaw, P., additional, Smets, Y., additional, Vleming, L.J., additional, Van Jaarsveld, B., additional, Honig, A., additional, and Siegert, C., additional
- Published
- 2017
- Full Text
- View/download PDF
31. MP330LOWER CALCIUM IS ASSOCIATED WITH KIDNEY FUNCTION DECLINE IN INDIVIDUALS WITH CHRONICKIDNEY DISEASE
- Author
-
Janmaat, C. J., primary, van Diepen, M., additional, Gasparini, A, additional, Evans, M., additional, Qureshi, A. R., additional, Arnlov, J., additional, Barany, P., additional, Elinder, C. G., additional, Rotmans, J. I., additional, Vervloet, M., additional, Dekker, F. W., additional, and Carrero, J. J., additional
- Published
- 2016
- Full Text
- View/download PDF
32. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery--development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study
- Author
-
Bell, S., primary, Dekker, F. W., additional, Vadiveloo, T., additional, Marwick, C., additional, Deshmukh, H., additional, Donnan, P. T., additional, and Van Diepen, M., additional
- Published
- 2015
- Full Text
- View/download PDF
33. Do Charities Get More when They Ask More Often? Evidence from a Unique Field Experiment
- Author
-
Donkers, A.C.D., van Diepen, M., and Franses, Ph.H.B.F.
- Subjects
jel:M ,competition, direct mailing, field experiment, fundraising ,jel:M31 ,jel:C44 - Abstract
Charitable organizations send out large volumes of direct mailings, soliciting for money in support of many good causes. Without any request, donations are rarely made, and it is well known that each request for money by a charity likely generates at least some revenues. Whether a single request from a charity increases the total amount donated by an individual is however unknown. Indeed, a response to one request can hurt responses to others. The net effect is therefore not easily observable, certainly not when multiple charities address the same individuals. In this paper we alleviate these observational difficulties by carrying out a field experiment in which five large charities cooperate. With the unique data that we collect, we study the impact of sending more requests on total donations. The results indicate that there is a negative competitive effect on requests from other charities, but this effect dies out rapidly. Soon after the mailing has been sent, it is only a strong cannibalization of the charity’s own revenues that prevails. This empirical finding suggests the important conclusion that not much coordination across charities is needed to increase revenues. We also demonstrate that charities need sophisticated evaluation tools that do not ignore the effects of cannibalization.
- Published
- 2010
34. Dynamics and competition in charitable giving
- Author
-
van Diepen, M, Franses, Philip Hans, Bronnenberg, BJ, Donkers, Bas, and Erasmus School of Economics
- Published
- 2009
35. Does irritation induced by charitable direct mailings reduce donation?
- Author
-
van Diepen, M, Donkers, Bas, Franses, Philip Hans, Erasmus School of Economics, and Econometrics
- Published
- 2009
36. Dynamic and competitive effects of direct mailings: a charitable giving application
- Author
-
van Diepen, M, Donkers, Bas, Franses, Philip Hans, Erasmus School of Economics, and Econometrics
- Published
- 2009
37. Does Irritation Induced by Charitable Direct Mailings Reduce Donations?
- Author
-
van Diepen, M., Donkers, A.C.D., and Franses, Ph.H.B.F.
- Subjects
jel:M ,jel:M31 ,education ,charity donations, direct marketing, field experiment, irritation ,jel:C44 - Abstract
Charities mainly rely on direct mailings to attract the attention of potential donators. Individuals may feel irritated by these mailings, in particular when they receive many mailings. We study the consequences of perceived irritation on stated behavior and on actual behavior. Target selection by charities likely results in good donators receiving many mailings and hence they might also be most irritated. Therefore, irritation with direct mailings might be endogenously determined. To create exogenous variation in irritation, we design a unique controlled field experiment in cooperation with five of the largest charities in the Netherlands. Our analysis reveals that direct mailings do result in irritation, but surprisingly this affects neither stated nor actual donating behavior.
- Published
- 2008
38. Bollen telen en broeien zonder veel tilwerk kan
- Author
-
Roelofs, P.F.M.M., Looije, A., Baltissen, A.H.M.C., Wildschut, J., and van Diepen, M.
- Subjects
crates ,hulpbronnen ,ornamental bulbs ,bloembollen ,ornamental crops ,ergonomie ,handarbeid ,forceren van planten ,gezondheidsbescherming ,health protection ,siergewassen ,optillen ,forcing ,ergonomics ,market gardens ,kratten ,manual work ,resources ,lifting ,tuinbouwbedrijven - Abstract
Stigas, Wageningen UR (WUR) en PPO Bloembollen zochten naar geschikte oplossingen om een groot deel van het zware werk uit handen te kunnen nemen door bij de ontwikkeling van een uniforme fust voor de bloembollensector rekening te houden met de ergonomische aanbevelingen kan ook het resterende handwerk gemakkelijker gemaakt worden
- Published
- 2007
39. Ergonomische adviezen bij de ontwikkeling van uniform fust voor bloemenbollen = Ergonomic advices concerning standardized flower bulbs crates
- Author
-
Roelofs, P.F.M.M., Baltissen, A.H.M.C., van Diepen, M., and Looije, A.A.J.
- Subjects
PPO Bloembollen en Bomen ,AFSG Agrisystems & Environment ,working conditions ,ornamental bulbs ,bloembollen ,Agrotechnology and Food Sciences ,Agrotechnologie en Levensmiddelentechnologie ,physical pressure ,arbeidsomstandigheden ,ergonomie ,labour ,arbeid (werk) ,optillen ,Nursery Stock-Flower Bulbs ,ergonomics ,fysieke belasting ,pallets ,lifting ,Wageningen Livestock Research - Abstract
In 2006 a study is done to generate ergonomic advices with respect to the design of a standardized crate that is to be used in flower bulb cultivation and flower bulb trade. Reason for this study was an earlier AKK study, which concluded that standardisation of the crates will reduce costs (particularly for transport) and improve flower bulb quality. Therefore, companies in this sector try to implement standardized crates.The aim of the present study was to give ergonomic advices concerning the layout of these crates, resulting in reduction of the physical load during manual handling of them. Another goal was to satisfy the people who will have to work with the crates, by respecting their wishes and requirements as far as possible.In close cooperation with the manager of the AKK-study, labour-related questions which remained unanswered in that study are inventoried. Further, according to the method `ergonomic design, additional wishes of the people who will have will work with the standardised crates have been formulated. Finally is examined how the inventoried requirements and wishes can be fulfilled. For that purpose the questions were answered, based on literature reviews, measurements and expertise.Some of the most important results are that:Physical load is lower during the lifting of 40x60 cm crates than during the lifting of 50x75 cm crates with the same weight.The physical load during the lifting of low standing crates reduces when the crates (and therefore handles) are as high as possible, but this effect is very small. Since the height of the piles is limited by other factors, no effect of crate altitude on physical load is expected when crates have to be moved from or to a high level. Without the use of special tools the physical load is always too high when piles are higher than 1.70 m. But even in ideal conditions the lifting of 15 or 20 kg crates to an altitude of 1.70 m results in a Lifting Index of 1.1 or 1.4 respectively, what is higher than the health standard.For handles, a dimension of 125x40 mm is recommended. Sharp edges must be avoided and it must be impossible to put sharp objects, such as staples, through the handles.Closed handles prevent that bulbs fall through the handles. Physical load when crates are taken from or placed on a high pile can be reduced al little when these handles are not only at the top of the crates, but also halfway.No large effect of standardisation of the layout of the crates on mechanisation is expected, since nearly all tools do not pick up the crates but grip them. Standardisation of the format (40x60 cm) is important, however, and the sides must be exactly rectangular.For transport in conditioned sea containers (inner width 2.26 or 2.28 m.) 100x120 cm pallets are most suitable. However, physical load during manual piling up of crates on these pallets is higher than when 80x100 cm pallets are used. In both cases the health limits are largely exceeded during manual handling of the crates.If crates with different altitudes must become piled up on the same pallet, tuning of the altitude of the different crates is needed. Good examples are 18 and 24 cm or 16.5 and 22 cm. If it must be possible to read the information on the crates automatically, transponders (chips) are preferred over bar codes. It is recommended to apply a low-frequency system and to give all crates only a unique number. A central database can contain information concerning the contents of all crates.The recommendations in this report answer different questions and some of them can not be combined with some others. For this reason the `ideal crate will be a combination of compromises. Therefore it is recommended - in accordance with the original design of this study to carry out a pilot before choosing definitively for one basic design for the standardized crates. In this pilot all users should be involved, and it is preferred to let them test a number of copies of the aimed types of cask. Voor de bloembollensector is het financieel aantrekkelijk over te schakelen naar uniformer fust. Op basis van ergonomische eisen en wensen aan dit fust zijn concrete aanbevelingen gedaan om bij de ontwikkeling of keuze van het geüniformeerde fust ook rekening te houden met de werkenden
- Published
- 2007
40. Irritation Due to Direct Mailings from Charities
- Author
-
van Diepen, M., Donkers, A.C.D., and Franses, Ph.H.B.F.
- Subjects
jel:M ,jel:M31 ,education ,DM, Direct Mail, Irritation, Junk Mail ,jel:C44 - Abstract
Direct mailing is the main tool that charities employ for fundraising. With increasing amounts of soliciting mailings and with the best donators receiving more mailings as a result of target selection, irritation might increase. As a result, such irritation could cause individuals to donate less, and hence reduce revenues for charities. We develop a conceptual model, which relates donating behavior to irritation and to mailing frequencies. We consider mailing frequencies relative to a reference point, which we call the maximum acceptance level. Furthermore, we allow for asymmetric effects of positive and negative differences with this maximum acceptance level, and hence we consider the effects of receiving excessive and acceptable amounts of mailings. To test our model empirically, we conduct a survey on charitable direct mailings and donating behavior among 213 respondents. We find that too many mailings do indeed lead to irritation, and that such irritation reduces annual donations.
- Published
- 2006
41. Dynamic and Competitive Effects of Direct Mailings
- Author
-
van Diepen, M, Donkers, Bas, Franses, Philip Hans, Erasmus School of Economics, and Business Economics
- Published
- 2006
42. Irritation Due to Direct Mailings from Charities
- Author
-
van Diepen, M, Donkers, Bas, Franses, Philip Hans, Erasmus School of Economics, and Business Economics
- Published
- 2006
43. Vermindering fysieke belasting tijdens fusthandling in de bloembollensector = Reducing physical load during crate handling in bulb cultivation
- Author
-
Roelofs, P.F.M.M., van Diepen, M., Looije, A.A.J., and Wildschut, J.
- Subjects
crates ,PPO Bloembollen en Bomen ,AFSG Agrisystems & Environment ,working conditions ,ornamental bulbs ,bloembollen ,Agrotechnology and Food Sciences ,Agrotechnologie en Levensmiddelentechnologie ,physical pressure ,arbeidsomstandigheden ,ergonomie ,labour ,arbeid (werk) ,optillen ,Nursery Stock-Flower Bulbs ,ergonomics ,gereedschappen ,tools ,kratten ,fysieke belasting ,pallets ,lifting ,Wageningen Livestock Research - Abstract
Een inventarisatie is gemaakt van hulpmiddelen die de fysieke belasting als gevolg van fusthandling in de bloembollen- en bolbloementeelt kan verminderen. Op praktijkbedrijven zijn de invloed op de fysieke belasting en de inzetbaarheid op verschillende plaatsen in het productieproces beoordeeld. Ook zijn jaarkosten berekend en te verwachten arbeidsbesparingen bepaald
- Published
- 2006
44. Evaluating CHAID
- Author
-
van Diepen, M, Franses, Philip Hans, and Erasmus School of Economics
- Published
- 2006
45. Evaluating chi-squared automatic interaction detection
- Author
-
van Diepen, M, Franses, Philip Hans, and Erasmus School of Economics
- Published
- 2006
46. Meer betaalgemak door de euro
- Author
-
Kippers, J, Franses, Philip Hans, van Diepen, M, Laheij, C, Tromp, N, and Erasmus School of Economics
- Published
- 2004
47. Increased risk for death and transplant failure after transplantation with kidneys from Expanded Criteria Donors in the Netherlands
- Author
-
van Ittersum, F.J., primary, van Diepen, M., additional, Hemke, A., additional, Dekker, F.W., additional, and Hoitsma, A., additional
- Published
- 2014
- Full Text
- View/download PDF
48. Increased risk for transplant failure after transplantation with kidneys donated after cardiac death in the Netherlands
- Author
-
van Ittersum, F.J., primary, van Diepen, M., additional, Hemke, A., additional, Dekker, F.W., additional, and Hoitsma, A., additional
- Published
- 2014
- Full Text
- View/download PDF
49. Improving a prediction model for renal patient survival
- Author
-
Hemke, A.C., primary, Heemskerk, M.B.A., additional, van Diepen, M., additional, Dekker, F.W., additional, and Hoitsma, A.J., additional
- Published
- 2014
- Full Text
- View/download PDF
50. Meer betaalgemak door de euro
- Author
-
van Diepen, M, Tromp, N, Franses, Philip Hans, Kippers, J, and Erasmus School of Economics
- Published
- 2003
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.